[1]
|
Bikbov, B., Purcell, C.A., Levey, A.S., et al. (2020) Global, Regional and National Burden of Chronic Kidney Disease, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet, 395, 709-733.
|
[2]
|
张艾佳, 张睿, 张睿. 单中心维持性血液透析患者的流行病学特征[J]. 中国老年学杂志, 2019, 39(18): 4514-4516.
|
[3]
|
Fox, C.S., Matsushita, K., Woodward, M., et al. (2012) Associations of Kidney Disease Measures with Mortality and End-Stage Renal Disease in Individuals with and without Diabetes: A Meta-Analysis of 1024977 Individuals. The Lancet, 380, 1662-1673. https://doi.org/10.1016/S0140-6736(12)61350-6
|
[4]
|
Mahmoodi, B.K., Matsushita, K., Woodward, M., et al. (2012) Associations of Kidney Disease Measures with Mortality and End-Stage Renal Disease in Individuals with and without Hypertension: A Meta-Analysis. The Lancet, 380, 1649-1661. https://doi.org/10.1016/S0140-6736(12)61272-0
|
[5]
|
Cozzolino, M., Mangano, M., Stucchi, A., Ciceri, P., Conte, F. and Galassi, A. (2018) Cardiovascular Disease in Dialysis Patients. Nephrology Dialysis Transplantation, 33, 1028-1034. https://doi.org/10.1093/ndt/gfy174
|
[6]
|
Bonomini, M., Del Vecchio, L., Sirolli, V. and Locatelli, F. (2016) New Treatment Approaches for the Anemia of CKD. American Journal of Kidney Diseases, 67, 133-142. https://doi.org/10.1053/j.ajkd.2015.06.030
|
[7]
|
Babitt, J.L. and Lin, H.Y. (2012) Mechanisms of Anemia in CKD. Journal of the American Society of Nephrology, 23, 1631-1634. https://doi.org/10.1681/ASN.2011111078
|
[8]
|
St Peter, W.L., Guo, H., Kabadi, S., et al. (2018) Prevalence, Treatment Patterns and Healthcare Resource Utilization in Medicare and Commercially Insured Non-Dialysis-Dependent Chronic Kidney Disease Patients with and without Anemia in the United States. BMC Nephrology, 19, 67-77.
|
[9]
|
Lacson, E.J., Wang, W., Hakim, R.M., Teng, M. and Lazarus, J.M. (2009) Associates of Mortality and Hospitalization in Hemodialysis: Potentially Actionable Laboratory Variables and Vascular Access. American Journal of Kidney Diseases, 53, 79-90. https://doi.org/10.1053/j.ajkd.2008.07.031
|
[10]
|
Toft, G., Heide-Jørgensen, U., van Haalen, H., et al. (2020) Anemia and Clinical Outcomes in Patients with Non-Dialysis Dependent or Dialysis Dependent Severe Chronic Kidney Disease: A Danish Population-Based Study. Journal of Nephrology, 33, 147-156. https://doi.org/10.1007/s40620-019-00652-9
|
[11]
|
Madhumathi, R., Brian, J.G. and Per-Eira, A. (2013) Prospective Trials on Anemia of Chronic Disease: The Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT). Kidney International, 64, S12-S19.
https://doi.org/10.1046/j.1523-1755.64.s87.21.x
|
[12]
|
Sud, M. and Naimark, D.M. (2016) Cardiovascular Disease in Chronic Kidney Disease in 2015. Current Opinion in Nephrology and Hypertension, 25, 203-207. https://doi.org/10.1097/MNH.0000000000000213
|
[13]
|
Deswal, A., Petersen, N.J., Feldman, A.M., Young, J.B., White, B.G. and Mann, D.L. (2001) Cytokines and Cytokine Receptors in Advanced Heart Failure: An Analysis of the Cytokine Database from the Vesnarinone Trial (VEST). Circulation, 103, 2055-2059. https://doi.org/10.1161/01.CIR.103.16.2055
|
[14]
|
van der Meer, P., Voors, A.A., Lipsic, E., Smilde, T.D., van Gilst, W.H. and van Veldhuisen, D.J. (2004) Prognostic Value of Plasma Erythropoietin on Mortality in Patients with Chronic Heart Failure. Journal of the American College of Cardiology, 44, 63-67. https://doi.org/10.1016/j.jacc.2004.03.052
|
[15]
|
Uhlig, K., Berns, J.S., Kestenbaum, B., et al. (2010) KDOQI US Commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD). American Journal of Kidney Diseases, 55, 773-799. https://doi.org/10.1053/j.ajkd.2010.02.340
|
[16]
|
吴珂, 彭荣. 高通量血液透析对维持性血液透析患者钙磷代谢及营养状况的影响[J]. 中外医学研究, 2021, 19(21): 171-173.
|
[17]
|
Foley, R.N., Parfrey, P.S., Harnett, J.D., et al. (2013) Hypocalcemia, Morbidity and Mortality in End-Stage Renal Disease. Nature Reviews Nephrology, 9, 438-439.
|
[18]
|
Lunyera, J. and Scialla, J.J. (2018) Update on Chronic Kidney Disease Mineral and Bone Disorder in Cardiovascular Disease. Seminars in Nephrology, 38, 542-558. https://doi.org/10.1016/j.semnephrol.2018.08.001
|
[19]
|
Naveh-Many, T. and Silver, J. (2017) The Pas de Trois of Vitamin D, FGF23 and PTH. Journal of the American Society of Nephrology, 28, 393-395. https://doi.org/10.1681/ASN.2016090944
|
[20]
|
Dominguez, J.R., Kestenbaum, B., Chonchol, M., et al. (2013) Relationships between Serum and Urine Phosphorus with All-Cause and Cardiovascular Mortality: The Osteoporotic Fractures in Men (MrOS) Study. American Journal of Kidney Diseases, 61, 555-563. https://doi.org/10.1053/j.ajkd.2012.11.033
|
[21]
|
Wang, T.K., Bolland, M.J., van Pelt, N.C., et al. (2010) Rela-tionships between Vascular Calcification, Calcium Metabolism, Bone Density and Fractures. Journal of Bone and Mineral Research, 25, 2777-2785.
https://doi.org/10.1002/jbmr.183
|
[22]
|
Bansal, N., Xie, D., Tao, K., et al. (2016) Atrial Fibrillation and Risk of ESRD in Adults with CKD. Clinical Journal of the American Society of Nephrology, 11, 1189-1196. https://doi.org/10.2215/CJN.10921015
|
[23]
|
Erben, R.G. and Andrukhova, O. (2017) FGF23-Klotho Signaling Axis in the Kidney. Bone, 100, 62-68.
|
[24]
|
Haynes, R. and Wheeler, D.C. (2013) Chronic Kidney Disease: Does Serum Phosphate Predict Death and ESRD in CKD Patients? Nature Reviews Nephrology, 9, 438-439. https://doi.org/10.1038/nrneph.2013.128
|
[25]
|
Hempel, J.C., Poppelaars, F., da Costa, M.G., Franssen, C.F., de Vlaam, T.P., Daha, M.R., Berger, S.P., Seelen, M.A.J. and Gaillard, C.A.J.M. (2017) Distinct In Vitro Complement Ac-tivation by Various Intravenous Iron Preparations. American Journal of Nephrology, 45, 49-59. https://doi.org/10.1159/000451060
|
[26]
|
Fukushi, T., Yamamoto, T., Yoshida, M., Fujikura, E., Miyazaki, M. and Nakayama, M. (2020) Enhanced Neutrophil Apoptosis Accompanying Myeloperoxidase Release during Hemodialysis. Scientific Reports, 10, Article No. 21747.
https://doi.org/10.1038/s41598-020-78742-z
|
[27]
|
Yoon, J.W., Pahl, M.V. and Vaziri, N.D. (2007) Spontaneous Leukocyte Activation and Oxygen-Free Radical Generation in End-Stage Renal Disease. Kidney International, 71, 167-172. https://doi.org/10.1038/sj.ki.5002019
|
[28]
|
Braunwald, E. and Kloner, R.A. (1982) The Stunned Myo-cardium: Prolonged, Postischemic Ventricular Dysfunction. Circulation, 66, 1146-1149. https://doi.org/10.1161/01.CIR.66.6.1146
|
[29]
|
Sun, J., Axelsson, J., Machowska, A., et al. (2016) Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD. Clinical Journal of the American Society of Nephrology, 11, 1163-1172.
https://doi.org/10.2215/CJN.10441015
|
[30]
|
Song, J.W., Song, K.S., Choi, J.R., et al. (2006) Plasma Level of IL-6 and Its Relationship to Procoagulant and Fibrinolytic Markers in Acute Ischemic Stroke. Yonsei Medical Journal, 47, 201-206.
https://doi.org/10.3349/ymj.2006.47.2.201
|
[31]
|
Schuett, H., Luchtefeld, M., Grothusen, C., Grote, K. and Schieffer, B. (2009) How Much Is too Much? Interleukin-6 and Its Signalling in Atherosclerosis. Thrombosis and Haemostasis, 102, 215-222.
https://doi.org/10.1160/TH09-05-0297
|
[32]
|
Palazzuoli, A., Gallotta, M., Iovine, F., et al. (2008) Anaemia in Heart Failure: A Common Inter Action with Renal Insufficiency Called the Cardio-Renal Anaemia Syndrome. International Journal of Clinical Practice, 62, 281-286.
https://doi.org/10.1111/j.1742-1241.2007.01650.x
|
[33]
|
Buckley, D.I., Fu, R., Freeman, M., Rogers, K. and Helfand, M. (2009) C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Me-ta-Analyses for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 151, 483-495. https://doi.org/10.7326/0003-4819-151-7-200910060-00009
|
[34]
|
饶甲环, 马煜盛, 龙洁旎, 等. 肾功能不全致心血管疾病机制的研究进展[J]. 广东医学, 2018, 39(15): 2388-2390.
|
[35]
|
Sircana, A., De Michieli, F., Parente, R., Framarin, L., Leone, N., Berrutti, M., Paschetta, E., Bongiovanni, D. and Musso, G. (2018) Gut Microbiota, Hyperten-sion and Chronic Kidney Disease: Recent Advances. Pharmacological Research, 144, 390-408.
|
[36]
|
李佳, 魏善斋, 孙杰, 等. 维持性血液透析患者促红细胞生成素抵抗与炎症反应和氧化应激反应的关系[J]. 山东医药, 2018, 58(28): 65-67. https://doi.org/10.3969/j.issn.1002-266X.2018.28.017
|
[37]
|
Haugen, E. and Nath, K.A. (1999) The Involvement of Oxidative Stress in the Progression of Renal Injury. Blood Purification, 17, 58-65. https://doi.org/10.1159/000014377
|
[38]
|
Locatelli, F., Canaud, B., Eckardt, K.U., Stenvinkel, P., Wanner, C. and Zoccali, C. (2003) Oxidative Stress in End- Stage Renal Disease: An Emerging Threat to Patient Outcome. Nephrology, Dialysis, Transplantation, 18, 1272-1280.
https://doi.org/10.1093/ndt/gfg074
|
[39]
|
Stenvinkel, P., Heimbürger, O., Paultre, F., Diczfalusy, U., Wang, T. and Berglund, L. (1999) Strong Association between Malnutrition, Inflammation and Atheroscle-rosis in Chronic Renal Failure. Kidney International, 55, 1899-1911.
https://doi.org/10.1046/j.1523-1755.1999.00422.x
|
[40]
|
Cai, H. and Harrison, D.G. (2000) Endothelial Dysfunction in Cardiovascular Diseases: The Role of Oxidant Stress. Circulation Research, 87, 840-844. https://doi.org/10.1161/01.res.87.10.840
|
[41]
|
Lambeth, J.D. (2004) Nox Enzymes and the Biology of Reactive Oxygen. Nature Reviews Immunology, 4, 181-189.
https://doi.org/10.1038/nri1312
|
[42]
|
Cave, A.C., Brewer, A.C., Narayanapanicker, A., Ray, R., Grieve, D.J., Walker, S. and Shah, A.M. (2006) NADPH Oxidases in Cardiovascular Health and Disease. Antioxidants & Redox Signaling, 8, 691-728.
https://doi.org/10.1089/ars.2006.8.691
|
[43]
|
Liu, Y., Xiao, X., Qin, D.P., et al. (2016) Comparison of Intradialytic Parenteral Nutrition with Glucose or Amino Acid Mixtures in Maintenance Hemodialysis Patients. Nutrients, 8, Article 220. https://doi.org/10.3390/nu8060220
|
[44]
|
Jofré, R., Rodriguez-Benitez, P., López-Gómez, J.M. and Pe-rez-Garcia, R. (2006) Inflammatory Syndrome in Patients on Hemodialysis. Journal of the American Society of Neph-rology, 17, S274-S280.
https://doi.org/10.1681/ASN.2006080926
|
[45]
|
郭花斌, 辛宝, 闫建锋, 等. 维持性血液透析患者营养不良相关因素研究综述[J]. 陇东学院学报, 2019, 30(5): 96-100.
|
[46]
|
Arikawa, R., Kanda, D., Ikeda, Y., Tokushige, A., Sonoda, T., Anzaki, K. and Ohishi, M. (2021) Prognostic Impact of Malnutrition on Cardiovascular Events in Coronary Artery Disease Patients with Myocardial Damage. BMC Cardiovascular Disorders, 21, Article No. 479. https://doi.org/10.1186/s12872-021-02296-9
|
[47]
|
Kootaka, Y., Kamiya, K., Hamazaki, N., Nozaki, K., Ichikawa, T., Nakamura, T., Yamashita, M., Maekawa, E., Reed, J.L., Yamaoka-Tojo, M., Matsunaga, A. and Ako, J. (2021) The GLIM Criteria for Defining Malnutrition Can Predict Physical Function and Prognosis in Patients with Cardiovascular Disease. Clinical Nutrition, 40, 146-152.
https://doi.org/10.1016/j.clnu.2020.04.038
|
[48]
|
Covinsky, K.E., Palmer, R.M., Fortinsky, R.H., Counsell, S.R., Stewart, A.L., Kresevic, D., et al. (2003) Loss of Independence in Activities of Daily Living in Older Adults Hospitalized with Medical Illnesses: Increased Vulnerability with Age. Journal of the American Geriatrics Society, 51, 451-458. https://doi.org/10.1046/j.1532-5415.2003.51152.x
|
[49]
|
Meyer, T.W. and Hostetter, T.H. (2012) Uremic Solutes from Colon Microbes. Kidney International, 81, 949-954.
https://doi.org/10.1038/ki.2011.504
|
[50]
|
Barreto, F.C., Barreto, D.V., Liabeuf, S., Meert, N., Glorieux, G., Temmar, M., Choukroun, G., Vanholder, R. and Massy, Z.A. (2009) Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients. Clinical Journal of the American Society of Nephrology, 4, 1551-1558.
https://doi.org/10.2215/CJN.03980609
|
[51]
|
Niwa, T. (2010) Uremic Toxicity of Indoxyl Sulfate. Nagoya Journal of Medical Science, 72, 1-11.
|
[52]
|
Hung, S.C., Kuo, K.-L., Huang, H.-L., Lin, C.C., Tsai, T.H., Wang, C.H., Chen, J.W., Lin, S.-J., Huang, P.H. and Tarng, D.-C. (2016) Indoxyl Sulfate Suppresses Endothelial Progenitor Cell-Mediated Neovascularization. Kidney International, 89, 574-585. https://doi.org/10.1016/j.kint.2015.11.020
|
[53]
|
Lano, G., Burtey, S. and Sallée, M. (2020) Indoxyl Sulfate, a Uremic Endotheliotoxin. Toxins, 12, Article 229.
https://doi.org/10.3390/toxins12040229
|
[54]
|
Chitalia, V.C., Shivanna, S., Martorell, J., Balcells, M., Bosch, I., Kolandaivelu, K. and Edelman, E.R. (2013) Uremic Serum and Solutes Increase Post—Vascular Interventional Thrombotic Risk through Altered Stability of Smooth Muscle Cell Tissue Factor. Circulation, 127, 365-376.
https://doi.org/10.1161/CIRCULATIONAHA.112.118174
|
[55]
|
Yang, K., Xu, X., Nie, L., Xiao, T., Guan, X., He, T., Yu, Y., Liu, L., Huang, Y., Zhang, J. and Zhao, J.H. (2015) Indoxyl Sulfate Induces Oxidative Stress and Hyper-trophy in Cardiomyocytes by Inhibiting the AMPK/UCP2 Signaling Pathway. Toxicology Letters, 234, 110-119. https://doi.org/10.1016/j.toxlet.2015.01.021
|
[56]
|
Meijers, B.K., Bammens, B., De Moor, B., Verbeke, K., Vanrenterghem, Y. and Evenepoel, P. (2008) Free P-Cresol Is Associated with Cardiovascular Disease in Hemodialysis Patients. Kidney International, 73, 1174-1180.
https://doi.org/10.1038/ki.2008.31
|
[57]
|
Wu, I.W., Hsu, K.H., Hsu, H.J., Lee, C.C., Sun, C.Y., Tsai, C.J. and Wu, M.S. (2012) Serum Free P-Cresyl Sulfate Levels Predict Cardiovascular and All-Cause Mortality in Elderly Hemodialy-sis Patients—A Prospective Cohort Study. Nephrology Dialysis Transplantation, 27, 1169-1175. https://doi.org/10.1093/ndt/gfr453
|
[58]
|
Shafi, T., Sirich, T.L., Meyer, T.W., et al. (2017) Results of the HEMO Study Suggest that P-Cresol Sulfate and Indoxyl Sulfate Are Not Associated with Cardiovascular Outcomes. Kidney International, 92, 1484-1492.
https://doi.org/10.1016/j.kint.2017.05.012
|
[59]
|
Gross, P., Massy, Z.A., Henaut, L., Boudot, C., Cagnard, J., March, C., Kamel, S., Drueke, T.B. and Six, I. (2015) Para-Cresyl Sulfate Acutely Impairs Vascular Reactivity and Induces Vascular Remodeling. Journal of Cellular Physiology, 230, 2927-2935. https://doi.org/10.1002/jcp.25018
|
[60]
|
Freise, C., Querfeld, U., Ludwig, A., Hamm, B., Schnorr, J. and Taupitz, M. (2021) Uraemic Extracellular Vesicles Augment Osteogenic Transdifferentiation of Vascular Smooth Muscle Cells via Enhanced AKT Signalling and PiT-1 Expression. Journal of Cellular and Molecular Medicine, 25, 5602-5614. https://doi.org/10.1111/jcmm.16572
|
[61]
|
Huang, S.S., Chen, Y.A., Chen, S.S., Chen, Y.J. and Lin, Y.K. (2016) Uremic Toxins—Novel Arrhythmogenic Factor in Chronic Kidney Disease—Related Atrial Fibrillation. Acta Cardiologica Sinica, 32, 259-264.
|